The company estimates the contract could generate between $20 million and $30 million in revenue once the product is delivered. Terms depend on the composition meeting specific sensory parameters that BioHarvest says will be finalized over the coming months. BioHarvest was founded in 2007 by Dr. Yochi Hagay and Dr. Zaki Rakib, with research operations in Rehovot, Israel, and a corporate base in Vancouver, Canada. The fragrance deal follows the company’s move into food ingredients through a sweetener partnership with Tate & Lyle and a separate saffron program with SaffronTech. “BioHarvest is transitioning from proving the breadth of our Botanical Synthesis technology across multiple industries to selectively converting our highest-value opportunities into recurring manufacturing revenue, royalties and sustainable profitability,” Rakib said.